Back

2019 ESC Guidelines on Supraventricular Tachycardias.

1 September 2019 (09:42 - 10:00)
Organised by:
Congress Presentation Part of: 2019 ESC Guidelines Overview Supraventricular Tachycardia (Non-Atrial Fibrillation) Open Access ESC Congress 2019

About the speakers

Photo
Professor Josep Brugada Terradellas

Hospital Clinic of Barcelona, Barcelona (Spain)

Photo
Doctor Demosthenes Katritsis

Hygeia Hospital, Athens (Greece)

4 More presentations in this session

Presentation thumbnail
2019 ESC Guidelines on Acute Pulmonary Embolism.
Professor S. Konstantinides (Mainz, DE) Professor G. Meyer (Paris, FR)
Slides Video
Presentation thumbnail
2019 ESC/EAS Guidelines on Dyslipidaemias.
Professor C. Baigent (Oxford, GB) Professor A. Catapano (Milan, IT)
Slides Video
Presentation thumbnail
2019 ESC Guidelines on Chronic Coronary Syndromes.
Professor J. Knuuti (Turku, FI) Professor W. Wijns (Brussels, BE)
Slides Video
Presentation thumbnail
2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the European Association for the Study of Diabetes (EASD).
Professor F. Cosentino (Stockholm, SE) Professor P. Grant (Leeds, GB)
Slides Video

Access the full session

Session thumbnail
2019 ESC Guidelines Overview

The Event

Event poster

ESC Congress 2019

1 September 2019 09:42 CET
You may be interested in
thumbnail
Congress Presentation
2019 ESC Guidelines for the management of patients with supraventricular tachycardia: did indications for catheter ablation change?
5 April 2022
thumbnail
Congress Presentation
Rhythm control in clinical practice: case presentation
1 September 2024
thumbnail
Congress Presentation
Analysis on the factors related to the acute success rate of fluoroless catheter ablation in patients with supraventricular tachycardias: a single-center experience
28 August 2020
thumbnail
Congress Session
When the rhythm is of the essence
18 May 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources